Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase
- PMID: 12700280
Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase
Abstract
Cells contain a large number of antioxidants to prevent or repair the damage caused by reactive oxygen species. One component of the antioxidant system, manganese superoxide dismutase (MnSOD), is localized in the mitochondria, and the levels of this protein have been previously shown to inversely correlate with pancreatic cancer cell growth. The aim of the present study was to determine whether MnSOD overexpression could suppress the in vitro and in vivo malignant phenotype of a human pancreatic cancer cell line. Tumor cell behavior was determined in the pancreatic cancer cell line MIA PaCa-2 by examining cell growth, plating efficiency, and anchorage-independent growth in soft agar. MnSOD was overexpressed in the pancreatic cancer cell line MIA PaCa-2 by infection with an adenovirus-MnSOD construct. Cells were also injected s.c. in nude mice and tumor volume was calculated. Single and multiple direct injections of the adenoviral MnSOD construct (10(9) plaque-forming units) were delivered to the tumor. Increases in MnSOD immunoreactivity and activity were seen after transduction with the adenovirus-MnSOD construct. Increasing MnSOD levels correlated with increased doubling time. Cell growth, plating efficiency, and growth in soft agar decreased with increasing amounts of the adenovirus MnSOD construct. Tumors grew slower and survival was increased in nude mice injected with the adenoviral MnSOD construct compared with the parental cell line, whereas multiple injections of the adenoviral MnSOD construct further inhibited tumor cell growth and extended survival. These results suggest that MnSOD may be a tumor suppressor gene in human pancreatic cancer. Delivery of the MnSOD gene may prove beneficial for suppression of pancreatic cancer growth.
Similar articles
-
The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma.Cancer Res. 2003 Mar 15;63(6):1297-303. Cancer Res. 2003. PMID: 12649190
-
Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma.Free Radic Res. 2004 Nov;38(11):1223-33. doi: 10.1080/10715760400017376. Free Radic Res. 2004. PMID: 15621700
-
Suppression of the malignant phenotype in pancreatic cancer by overexpression of phospholipid hydroperoxide glutathione peroxidase.Hum Gene Ther. 2006 Jan;17(1):105-16. doi: 10.1089/hum.2006.17.105. Hum Gene Ther. 2006. PMID: 16409129
-
Anticancer therapy by overexpression of superoxide dismutase.Antioxid Redox Signal. 2001 Jun;3(3):461-72. doi: 10.1089/15230860152409095. Antioxid Redox Signal. 2001. PMID: 11491657 Review.
-
Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.Curr Med Chem. 2004 May;11(10):1299-308. doi: 10.2174/0929867043365297. Curr Med Chem. 2004. PMID: 15134521 Review.
Cited by
-
Mechanisms of superoxide signaling in epigenetic processes: relation to aging and cancer.Aging Dis. 2015 Jun 1;6(3):216-27. doi: 10.14336/AD.2014.0924. eCollection 2015 Jun. Aging Dis. 2015. PMID: 26029480 Free PMC article. Review.
-
Dose-Dependent Effect of Mitochondrial Superoxide Dismutase Gene Overexpression on Radioresistance of HEK293T Cells.Int J Mol Sci. 2023 Dec 10;24(24):17315. doi: 10.3390/ijms242417315. Int J Mol Sci. 2023. PMID: 38139144 Free PMC article.
-
Depletion of Mdig Changes Proteomic Profiling in Triple Negative Breast Cancer Cells.Biomedicines. 2022 Aug 19;10(8):2021. doi: 10.3390/biomedicines10082021. Biomedicines. 2022. PMID: 36009568 Free PMC article.
-
Insights into the Dichotomous Regulation of SOD2 in Cancer.Antioxidants (Basel). 2017 Nov 3;6(4):86. doi: 10.3390/antiox6040086. Antioxidants (Basel). 2017. PMID: 29099803 Free PMC article. Review.
-
Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus.Onco Targets Ther. 2016 Oct 17;9:6381-6388. doi: 10.2147/OTT.S113014. eCollection 2016. Onco Targets Ther. 2016. PMID: 27799786 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical